Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E9QX
|
||||
Former ID |
DIB018118
|
||||
Drug Name |
(S)-PIA
|
||||
Synonyms |
(S)-PIA
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [467494] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H23N5O4
|
||||
InChI |
InChI=1S/C19H23N5O4/c1-11(7-12-5-3-2-4-6-12)23-17-14-18(21-9-20-17)24(10-22-14)19-16(27)15(26)13(8-25)28-19/h2-6,9-11,13,15-16,19,25-27H,7-8H2,1H3,(H,20,21,23)/t11-,13+,15+,16+,19+/m0/s1
|
||||
InChIKey |
RIRGCFBBHQEQQH-KFAHYOAQSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2b receptor | Target Info | Agonist | [525595] | |
Adenosine A1 receptor | Target Info | Agonist | [533981] | ||
Adenosine A3 receptor | Target Info | Agonist | [525758] | ||
Pathway Interaction Database | C-MYB transcription factor network | ||||
References | |||||
Ref 525595 | Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. Mol Pharmacol. 1999 Oct;56(4):705-13. | ||||
Ref 525758 | [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors. Mol Pharmacol. 2000 May;57(5):968-75. | ||||
Ref 533981 | A threonine residue in the seventh transmembrane domain of the human A1 adenosine receptor mediates specific agonist binding. J Biol Chem. 1994 Jan 28;269(4):2373-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.